Global Allergy Immunotherapies Market 2016-2020
About the Allergy Immunotherapies Market
Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an
established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes
increasing the doses of allergen extracts over a span of time either through injections or sublingual tablets and
drops.
Allergies occur when a foreign substance, which is mostly harmless, reacts with the immune system. These foreign
substances are called allergens. Some allergens that affect the immune system are animal dander, dust mite, pollens,
cockroach, and mold. Animal dander, dust mite, and mold cause indoor allergies.
There are various types of allergies, including rhinitis, asthma, eye allergy, and skin allergy. Sometimes, severe
allergies can lead to death, as the severity of these allergic reactions interfere with the proper function of organs.
For instance, allergic rhinitis and asthma cause the lungs to function poorly.
Publisher's analysts forecast the global allergy immunotherapies market to grow at a CAGR of 7.3% during the
period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global allergy immunotherapies market for
2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and
generic drugs used to treat allergic diseases such as allergic rhinitis and allergic asthma. It also considers the
revenues to be generated from the sales of drugs that are expected to be launched into the market along with the
decline in revenues from the patent expiries of the marketed drugs during the forecast period.
View Complete Report @ http://www.reportsweb.com/global-allergy-immunotherapies-market-2016-
2020
Contact Us : +91-20-67278686 | E-Mail : [email protected]